CDT Equity Inc. SEC filings CDT

CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

CDT Equity Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Nov 4, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Nov 4, 2026 Nov 2, 2026
424B3 Prospectus Nov 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
DEF 14A Proxy statement Oct 27, 2026 Oct 27, 2026
4 Insider transaction Oct 27, 2026 Oct 22, 2026
4/A Filing Oct 27, 2026 Jul 30, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 27, 2026 —
3 Initial insider ownership Oct 27, 2026 Oct 22, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 27, 2026 Oct 22, 2026
PRE 14A Preliminary proxy statement Oct 16, 2026 Oct 16, 2026
424B3 Prospectus Oct 13, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 13, 2026 Oct 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 8, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
424B3 Prospectus Oct 2, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 25, 2026 Sep 24, 2026
424B3 Prospectus Sep 18, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 18, 2026 Sep 14, 2026
424B3 Prospectus Sep 18, 2026 —
EFFECT Filing Sep 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Sep 9, 2026 —
S-1 Registration statement Sep 8, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 4, 2026 Aug 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 2, 2026 —
4 Insider transaction Sep 2, 2026 Jul 30, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 2, 2026 —
8-K Current report
Other events
Sep 1, 2026 Aug 28, 2026
8-K Current report
Officer or director change, Shareholder vote results
Sep 1, 2026 Aug 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 21, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 21, 2026 —
8-K/A Amended current report Aug 21, 2026 Jul 30, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 21, 2026 Feb 19, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
DEFA14A Additional proxy material Aug 12, 2026 —
ARS Annual report to shareholders Aug 11, 2026 Dec 31, 2025
DEF 14A Proxy statement Aug 11, 2026 Aug 11, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 6, 2026 Jul 31, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 3, 2026 Jul 30, 2026
PRE 14A Preliminary proxy statement Jul 31, 2026 Jul 31, 2026
8-K Current report
Material agreement, Unregistered share sale
Jul 31, 2026 Jul 30, 2026
8-K Current report
Unregistered share sale
Jul 29, 2026 Jul 24, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
10-Q Quarterly report Jul 15, 2026 Mar 31, 2026
8-K Current report
Material agreement, New debt
Jul 7, 2026 Jun 30, 2026
8-K Current report
Auditor change
Jun 29, 2026 Jun 23, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 23, 2026 —
4 Insider transaction Jun 23, 2026 Jun 18, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 16, 2026 Jun 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 5, 2026 —
8-K Current report
Listing notice, Regulation FD disclosure
May 28, 2026 May 21, 2026
SCHEDULE 13G Ownership over 5% (passive) May 20, 2026 —
NT 10-Q Filing May 15, 2026 Mar 31, 2026
8-K Current report
Material agreement
May 15, 2026 May 15, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 14, 2026 —
4 Insider transaction May 14, 2026 Mar 24, 2026
EFFECT Filing May 1, 2026 —
424B3 Prospectus May 1, 2026 —
3 Initial insider ownership Apr 30, 2026 Apr 27, 2026
CORRESP Letter to the SEC Apr 30, 2026 —
UPLOAD Letter from the SEC Apr 29, 2026 —
8-K Current report
Officer or director change
Apr 27, 2026 Apr 27, 2026
S-3 Shelf registration Apr 22, 2026 —
10-K Annual report Apr 15, 2026 Dec 31, 2025
424B5 Prospectus supplement Apr 2, 2026 —
NT 10-K Filing Apr 1, 2026 Dec 31, 2025
4 Insider transaction Mar 30, 2026 Feb 19, 2026
3 Initial insider ownership Mar 30, 2026 Feb 19, 2026
SCHEDULE 13D Ownership over 5% (active) Mar 30, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 25, 2026 Mar 24, 2026
8-K Current report
Shareholder vote results
Mar 18, 2026 Mar 17, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 9, 2026 Mar 3, 2026
DEF 14A Proxy statement Mar 6, 2026 Mar 6, 2026
8-K Current report
Material agreement, Unregistered share sale
Feb 24, 2026 Feb 19, 2026
PRE 14A Preliminary proxy statement Feb 24, 2026 Feb 24, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
424B3 Prospectus Feb 10, 2026 —
EFFECT Filing Feb 9, 2026 —
CORRESP Letter to the SEC Feb 6, 2026 —
UPLOAD Letter from the SEC Feb 6, 2026 —
S-8 Employee stock plan registration Jan 30, 2026 —
S-3 Shelf registration Jan 30, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jan 22, 2026 Jan 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 2, 2026 Dec 28, 2025
4 Insider transaction Dec 22, 2025 Dec 8, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 22, 2025 —
S-8 POS Filing Dec 12, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 12, 2025 Dec 8, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Oct 9, 2025 Oct 8, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 22, 2025 —
4 Insider transaction Sep 22, 2025 Sep 19, 2025
4 Insider transaction Sep 19, 2025 Sep 19, 2025
4 Insider transaction Aug 26, 2025 Aug 5, 2025
4 Insider transaction Aug 26, 2025 Aug 5, 2025
4 Insider transaction Aug 26, 2025 Aug 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 18, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q/A Amended quarterly report Aug 14, 2025 Mar 31, 2025
8-K Current report
Restatement
Aug 14, 2025 Aug 8, 2025
424B3 Prospectus Aug 12, 2025 —
S-8 Employee stock plan registration Aug 11, 2025 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Aug 8, 2025 Aug 4, 2025
EFFECT Filing Aug 7, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 31, 2025 —
S-3 Shelf registration Jul 31, 2025 —
DEF 14A Proxy statement Jul 8, 2025 Jul 8, 2025
ARS Annual report to shareholders Jul 8, 2025 Dec 31, 2024
4 Insider transaction Jun 13, 2025 Jun 3, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 9, 2025 Jun 3, 2025
8-K Current report Jun 3, 2025 Jun 3, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
May 16, 2025 May 15, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
SCHEDULE 13G Ownership over 5% (passive) May 7, 2025 —
3 Initial insider ownership May 7, 2025 Mar 31, 2025
8-K Current report
Shareholder vote results
May 6, 2025 May 5, 2025
EFFECT Filing Apr 30, 2025 —
CORRESP Letter to the SEC Apr 28, 2025 —
UPLOAD Letter from the SEC Apr 28, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
8-K Current report
Auditor change
Apr 25, 2025 Apr 24, 2025
S-3 Shelf registration Apr 22, 2025 —
4 Insider transaction Apr 17, 2025 Apr 16, 2025
PRE 14A Preliminary proxy statement Apr 16, 2025 Apr 16, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 16, 2025 Apr 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 10, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Apr 4, 2025 Mar 31, 2025
8-K/A Amended current report
Other events
Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 1, 2025 Mar 30, 2025
4 Insider transaction Apr 1, 2025 Mar 30, 2025
4 Insider transaction Apr 1, 2025 Mar 30, 2025
4 Insider transaction Apr 1, 2025 Mar 30, 2025
8-K Current report
Other events
Apr 1, 2025 Mar 31, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
424B5 Prospectus supplement Mar 10, 2025 —
8-K Current report
Other events
Mar 6, 2025 Mar 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 20, 2025 —
8-K Current report
Agreement ended, Listing notice, Other events
Feb 19, 2025 Feb 12, 2025
424B5 Prospectus supplement Feb 19, 2025 —
424B3 Prospectus Feb 14, 2025 —
EFFECT Filing Feb 12, 2025 —
CORRESP Letter to the SEC Feb 11, 2025 —
UPLOAD Letter from the SEC Feb 11, 2025 —
8-K Current report
Other events
Feb 11, 2025 Feb 7, 2025
424B5 Prospectus supplement Feb 10, 2025 —
S-8 Employee stock plan registration Feb 6, 2025 —
424B5 Prospectus supplement Feb 6, 2025 —
S-3 Shelf registration Feb 5, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jan 23, 2025 Jan 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2025 —
424B5 Prospectus supplement Jan 15, 2025 —
8-K Current report
Shareholder vote results
Jan 14, 2025 Jan 13, 2025
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
3 Initial insider ownership Dec 20, 2024 Dec 18, 2024
8-K Current report
Listing notice, Shareholder vote results
Dec 20, 2024 Dec 17, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 17, 2024 Dec 12, 2024
424B3 Prospectus Dec 16, 2024 —
424B3 Prospectus Dec 9, 2024 —
DEF 14A Proxy statement Dec 6, 2024 Dec 6, 2024
EFFECT Filing Dec 6, 2024 —
CORRESP Letter to the SEC Dec 4, 2024 —
UPLOAD Letter from the SEC Dec 2, 2024 —
PRE 14A Preliminary proxy statement Nov 26, 2024 Nov 26, 2024
S-3 Shelf registration Nov 25, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 25, 2024 Nov 22, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Nov 19, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q/A Amended quarterly report Nov 14, 2024 Jun 30, 2024
10-Q/A Amended quarterly report Nov 14, 2024 Mar 31, 2024
8-K Current report
Restatement
Nov 14, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
424B5 Prospectus supplement Nov 4, 2024 —
424B3 Prospectus Nov 4, 2024 —
EFFECT Filing Nov 1, 2024 —
DEFA14A Additional proxy material Nov 1, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Nov 1, 2024 Oct 28, 2024
CORRESP Letter to the SEC Oct 31, 2024 —
UPLOAD Letter from the SEC Oct 29, 2024 —
ARS Annual report to shareholders Oct 28, 2024 Dec 31, 2023
DEFA14A Additional proxy material Oct 28, 2024 —
DEF 14A Proxy statement Oct 28, 2024 Oct 28, 2024
S-3 Shelf registration Oct 24, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
PRE 14A Preliminary proxy statement Oct 16, 2024 Oct 16, 2024
8-K Current report
Material agreement, New debt
Oct 15, 2024 Oct 9, 2024
SC 13G Ownership over 5% (passive) Oct 11, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CDT (Nasdaq), CDTTW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Naples, FL
SEC filer status
, Emerging growth company
SEC CIK
1896212
Former names
CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.